DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Information source: Wyeth
Information obtained from ClinicalTrials.gov on August 03, 2007
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Ankylosing Spondylitis

Status: Recruiting

Sponsored by: Wyeth

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth Research
Trial Manager, Principal Investigator, Affiliation: MedinfoDEU@wyeth.com

Overall contact:
Trial Manager, Email: clintrialparticipation@wyeth.com

Summary

The purpose of this study is to investigate the incidence of adverse events for patients with AS treated with Enbrel in usual care settings.

Clinical Details

Official title: Observational Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Study design: Observational, Natural History, Cross-Sectional, Defined Population, Prospective Study

Eligibility

Minimum age: 18 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Diagnosis of ankylosing spondylitis

Exclusion Criteria:

- Contraindications according SmPC

Locations and Contacts

Trial Manager, Email: clintrialparticipation@wyeth.com

Berlin 10719, Germany; Recruiting
Additional Information

Starting date: May 2004
Last updated: May 22, 2007

Page last updated: August 03, 2007

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014